| Year |
Citation |
Score |
| 2019 |
Fraunhoffer KJ, DelMonte AJ, Beutner GL, Bultman MS, Camacho K, Cohen B, Dixon DD, Fan Y, Fanfair D, Freitag AJ, Glace AW, Gonzalez-Bobes F, Gujjar M, Haley MW, Hickey MR, et al. Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor Organic Process Research & Development. 23: 2482-2498. DOI: 10.1021/Acs.Oprd.9B00359 |
0.413 |
|
| 2017 |
Bultman MS, Fan J, Fanfair D, Soltani M, Simpson J, Murugesan S, Soumeillant M, Chen K, Risatti C, La Cruz TE, Buono FG, Hung V, Schild RL, Ivy S, Sweeney JT, et al. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 4. Synthesis of the 6-Azaindole Core Organic Process Research & Development. 21: 1131-1136. DOI: 10.1021/Acs.Oprd.7B00152 |
0.483 |
|
| 2017 |
La Cruz TE, Saurer EM, Engstrom J, Bultman MS, Forest R, Akpinar F, Ferreira G, Ho JW, Huang M, Soltani M, Murugesan S, Fanfair D, Ramirez A, Rosso VW, Erdemir D, et al. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 9. Active Pharmaceutical Ingredient Process Development and Powder Properties Organic Process Research & Development. 21: 1174-1185. DOI: 10.1021/Acs.Oprd.7B00138 |
0.371 |
|
| 2017 |
Zheng B, Silverman SM, Steinhardt SE, Kolotuchin S, Iyer V, Fan J, Skliar D, McLeod DD, Bultman M, Tripp JC, Murugesan S, La Cruz TE, Sweeney JT, Eastgate MD, Conlon DA. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 6. Friedel–Crafts Acylation/Hydrolysis and Amidation Organic Process Research & Development. 21: 1145-1155. DOI: 10.1021/Acs.Oprd.7B00133 |
0.479 |
|
| 2017 |
González-Bobes F, Hickey MR, Cohen B, Bultman M, Chen K, Fanfair D, Rosso VW, Strotman NA, Mudryk B, Murugesan S, Schild RL, Ivy S, Eastgate MD, Sweeney JT, Conlon DA. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 5. Selective C-7 Bromination of the 6-Azaindole Core Organic Process Research & Development. 21: 1137-1144. DOI: 10.1021/Acs.Oprd.7B00132 |
0.475 |
|
| 2017 |
Chen K, Risatti C, Simpson J, Soumeillant M, Soltani M, Bultman M, Zheng B, Mudryk B, Tripp JC, La Cruz TE, Hsiao Y, Conlon DA, Eastgate MD. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 2. Strategic Selections in the Transition from an Enabling Route to a Commercial Synthesis Organic Process Research & Development. 21: 1110-1121. DOI: 10.1021/Acs.Oprd.7B00121 |
0.449 |
|
| 2017 |
Beutner GL, Albrecht J, Fan J, Fanfair D, Lawler MJ, Bultman M, Chen K, Ivy S, Schild RL, Tripp JC, Murugesan S, Dambalas K, McLeod DD, Sweeney JT, Eastgate MD, et al. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 3. Mechanistic Studies Enable a Scale-Independent Friedel–Crafts Acylation Organic Process Research & Development. 21: 1122-1130. DOI: 10.1021/Acs.Oprd.7B00115 |
0.428 |
|
| 2015 |
Ortiz A, Benkovics T, Beutner GL, Shi Z, Bultman M, Nye J, Sfouggatakis C, Kronenthal DR. Scalable Synthesis of the Potent HIV Inhibitor BMS-986001 by Non-Enzymatic Dynamic Kinetic Asymmetric Transformation (DYKAT). Angewandte Chemie (International Ed. in English). 54: 7185-8. PMID 25925234 DOI: 10.1002/Anie.201502290 |
0.467 |
|
| 2014 |
Chen K, Risatti C, Bultman M, Soumeillant M, Simpson J, Zheng B, Fanfair D, Mahoney M, Mudryk B, Fox RJ, Hsaio Y, Murugesan S, Conlon DA, Buono FG, Eastgate MD. Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068. The Journal of Organic Chemistry. 79: 8757-67. PMID 25144249 DOI: 10.1021/Jo5016008 |
0.515 |
|
| 2008 |
Bultman MS, Ma J, Gin DY. Synthetic access to the chlorocyclopentane cores of the proposed original and revised structures of palau'amine. Angewandte Chemie (International Ed. in English). 47: 6821-4. PMID 18655078 DOI: 10.1002/Anie.200801969 |
0.436 |
|
| 2005 |
Kongprakaiwoot N, Bultman MS, Luck RL, Urnezius E. Synthesis and structural characterizations of para-bis(dialkyl/ diarylphosphino)phenylenes built around tetrahalogenated benzene cores Inorganica Chimica Acta. 358: 3423-3429. DOI: 10.1016/J.Ica.2005.04.016 |
0.345 |
|
| Show low-probability matches. |